awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35736293-FE5B4D2B-03E1-4B56-BBE6-C1587D015D96
Q35736293-FE5B4D2B-03E1-4B56-BBE6-C1587D015D96
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35736293-FE5B4D2B-03E1-4B56-BBE6-C1587D015D96
Cost-effectiveness of sofosbuvir-based treatments for chronic hepatitis C in the US.
P2860
Q35736293-FE5B4D2B-03E1-4B56-BBE6-C1587D015D96
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35736293-FE5B4D2B-03E1-4B56-BBE6-C1587D015D96
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1c46353ace3c07db98be1d38c41a7b15c602d936
P2860
Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C.